Clinical trials: SARS-CoV Infection
COVID-19, SARS-CoV 2
Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)
In this pilot trial, 150 confirmed COVID-19 individuals will be randomly assigned to 1 of 5 groups: distilled water, CloSYS Ultra Sensitive Rinse (Rowpar Pharmaceutical Inc., USA), Oral-B Mouth Sore (Oral-B, USA), Crest…
- Conditions
- COVID-19, SARS-CoV 2, Severe Acute Respiratory Syndrome Coronavirus 2, Virus Disease
- Trial name
- AMPoL (NCT04409873)
- Testing
- Oral-B Mouth Sore mouthwash, Crest Pro-Health Multi-Protection mouthwash, CloSYS Ultra Sensitive Rinse mouthwash
- Where
- United States
- Volunteers
- 54 people
- Sponsor
- University of California, San Francisco
Corona Virus Infection, SARS-CoV 2
Registry for Clinical Presentation and Management of Patients With COVID-19 in the Emergency Room
Patients with COVID-19 usually present in the ED and receive their initial medical check-up here. We will try to gather information of comorbidities and other conditions at the time of presentation of COVID-19 patients to the ED.
- Trial name
- ReCovER (NCT04351854)
- Testing
- Retrospective data collection
- Where
- Germany
- Volunteers
- 500 people
- Sponsor
- University of Cologne
COVID-19, SARS-CoV 2
Carrageenan Nasal Spray for COVID-19 Prophylaxis
The current COVID-19 pandemic is the biggest global healthcare challenge in the last century, and the number of cases in the next 12 months is likely to increase.
- Trial name
- ICE-COVID (NCT04590365)
- Testing
- Carrageenan nasal and throat spray, Saline nasal and throat spray
- Where
- United Kingdom
- Volunteers
- 480 people, healthy volunteers welcome
- Sponsor
- Swansea University
Covid19, Coronavirus
Lung Ultrasound Changes in Covid 19 Patients Discharged From Hospital
Lung ultrasound has been used to help diagnose COVID-19 as an alternative to CT scanning and chest X-ray. CT scanning is onerous and there are difficulties taking critically unwell patients there as well as decontamination…
- Conditions
- Covid19, Coronavirus, Coronavirus Infection, SARS-CoV Infection
- Trial name
- NCT05062603
- Where
- United Kingdom
- Volunteers
- 23 people
- Sponsor
- Chelsea and Westminster NHS Foundation Trust
Covid19
Seroprevalence of SARS-CoV-2 in Asymptomatic Frontline COVID-19 HCWs
This study is about the current knowledge on the immunological changes observed in various healthcare workers in this part of the world, who remained asymptomatic while working in high exposure areas of COVID-19 infection.
- Trial name
- NCT04563247
- Testing
- IgG SARS CoV 2 antibodies
- Where
- Pakistan
- Volunteers
- 970 people
- Sponsor
- Lahore General Hospital
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2 Infection), COVID-19
SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19
The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effective and safe in adults with COVID-19 who do not need to be in the hospital but who are at high risk for progression to severe disease.
- Trial name
- NCT05629962
- Testing
- Bemnifosbuvir (BEM)
- Where
- 263 sites in United States, Argentina and 17 more
- Volunteers
- 2,285 people
- Sponsor
- Atea Pharmaceuticals, Inc.
SARS-CoV 2
Exploring Brain Damages After COVID-19 Infection
Although direct evidence is currently lacking, the high identity between SARS-CoV-1 and SARS-CoV-2 suggests, that the latter viral strain could also infect the Central Nervous System (CNS).
- Trial name
- BRAINCOV (NCT04405986)
- Testing
- Auditory Evoked Potentials (AEP), Blink and Masseter Inhibitory Reflex
- Where
- France
- Volunteers
- 38 people
- Sponsor
- University Hospital, Bordeaux
SARS-CoV Infection, Vitamin D Deficiency
Influence of Military Preventive Policy for reCruit Training on COVID-19 Seroconversion
This study is intended to address the association between vitamin D status and seroconversion to SARS-CoV-2 in healthy young adults.
- Conditions
- SARS-CoV Infection, Vitamin D Deficiency, Covid19, Acute Respiratory Tract Infection
- Trial name
- IMPACTCOVID (NCT04476680)
- Testing
- Vitamin D
- Where
- 2 sites in United Kingdom
- Volunteers
- 900 people, healthy volunteers welcome
- Sponsor
- Royal Centre for Defence Medicine
COVID-19, Neuro-Degenerative Disease
Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19
The pandemic caused by SARS-CoV-2 infection has led to the emergence of diffuse and heterogeneous persistent symptoms in addition to the well-known acute symptoms, which have come to be referred to as persistent COVID.
- Conditions
- COVID-19, Neuro-Degenerative Disease, Psychological, SARS CoV 2 Infection
- Trial name
- COPERIA-COG (NCT05629897)
- Testing
- Sessions of cognitive stimulation
- Where
- 2 sites in Spain
- Volunteers
- 88 people
- Sponsor
- Fundacin Biomedica Galicia Sur